Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2014 08:00 ET | Source: Receptos, Inc.

Receptos to Hold Fourth Quarter and Year End 2013 Financial Results Conference Call and Webcast

SAN DIEGO, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, will...
January 14, 2014 09:46 ET | Source: Receptos, Inc.

Receptos Announces Closing of Underwritten Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN DIEGO, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced...
January 08, 2014 21:41 ET | Source: Receptos, Inc.

Receptos Announces Pricing of Underwritten Public Offering of Common Stock

SAN DIEGO, Jan. 8, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced...
January 06, 2014 16:05 ET | Source: Receptos, Inc.

Receptos Begins Enrollment of Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis

– Pivotal Phase 3 Trial is Underway with First Patients Randomized in December 2013 – – Topline Results of Phase 2 Still Expected in Mid-2014...
January 06, 2014 16:05 ET | Source: Receptos, Inc.

Receptos Announces Proposed Underwritten Public Offering of Common Stock

SAN DIEGO, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced...
December 10, 2013 16:05 ET | Source: Receptos, Inc.

Receptos and Ono Pharmaceuticals Expand Collaboration Agreement to Include Transfer of Receptos GPCR Technology Platform

SAN DIEGO, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) announced today that Ono has elected to amend and expand the existing collaboration agreement between the parties to include...
December 05, 2013 08:00 ET | Source: Receptos, Inc.

Receptos to Initiate Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis

– Data from Interim Analysis of Phase 2 Trial Provide Support to Advance Program – – Interim Data Consistent with RPC1063 Differentiation Profile –...
November 26, 2013 08:00 ET | Source: Receptos, Inc.

Christian Waage Appointed General Counsel of Receptos

SAN DIEGO, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) announced today that Christian Waage has been appointed Senior Vice President and General Counsel of the Company. Mr. Waage...
November 11, 2013 08:00 ET | Source: Receptos, Inc.

Receptos to Present at 2013 Credit Suisse Healthcare Conference

SAN DIEGO, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...
October 30, 2013 16:22 ET | Source: Receptos, Inc.

Receptos Reports Third Quarter 2013 Financial Results

- Phase 2 trial of RPC1063 in relapsing multiple sclerosis has completed enrollment; interim results to be reviewed in Q4 2013 - - Phase 2 trial of RPC1063 in ulcerative colitis continues to...